Author | Tim Iveson, MD, FACP | OncLive

Author | Tim Iveson, MD, FACP


Dr. Iveson on the IDEA Collaboration in CRC

August 14, 2019


Tim Iveson, MD, FACP, discusses the International Duration Evaluation of Adjuvant Chemotherapy Collaboration, which examines the effects of adjuvant oxaliplatin-based therapy given for 3 months versus 6 months in patients with high-risk stage II colorectal cancer.